HPX

HPX Full Name

hemopexin

HPX Introduction

Hemopexin (HPX) is a plasma glycoprotein primarily synthesized in the liver and is the primary high-affinity heme-binding protein in the bloodstream. It has a molecular weight of approximately 60 kDa and is structurally characterized by the presence of two four-bladed β-propeller domains connected by a linker region, forming a characteristic pocket that tightly binds heme. As an acute-phase protein, its synthesis is upregulated during inflammation, infection, and hemolytic conditions. This strategic production ensures an enhanced capacity to scavenge toxic free heme, positioning hemopexin as a crucial component of the body's antioxidant and iron-conserving defense systems.

Figure 1. Crystal structure of the hemopexin.

HPX exhibits significant clinical relevance, with its plasma levels serving as a valuable biomarker for assessing disease progression and prognosis, particularly in hematological and hemolytic disorders. In conditions characterized by heme overload—including sickle cell disease, transfusion-induced hemolysis, sepsis, and hemolytic-uremic syndrome—endogenous HPX levels are often depleted, leaving the body vulnerable to heme toxicity. Conversely, elevated HPX levels have been observed in diabetes mellitus, hemochromatosis, and some rapidly growing melanomas, highlighting its role as a versatile diagnostic indicator. Beyond its diagnostic value, HPX holds therapeutic potential: strategies such as HPX supplementation for depleted endogenous levels and structural modifications to enhance its functionality are being explored to mitigate heme toxicity in hemolytic diseases, though its "double-edged" nature—exerting deleterious effects under certain conditions, such as exacerbating globin-mediated neurotoxicity in the absence of haptoglobin—must be considered.

In summary, hemopexin is a multifunctional glycoprotein that plays a pivotal role in heme detoxification, iron homeostasis, and the body's response to inflammatory and hemolytic stressors. Its unique ability to bind heme with unmatched affinity, coupled with its role in receptor-mediated heme processing, makes it an indispensable component of the body's defense system against heme-induced damage. While significant progress has been made in understanding HPX's structure and functions, gaps remain in elucidating its precise mechanisms of action in various disease contexts and its potential side effects in therapeutic applications. Future research focusing on HPX modification technologies, its crosstalk with other heme-binding proteins (such as haptoglobin), and its role in emerging disease models will further unlock its clinical potential, paving the way for novel diagnostic tools and targeted therapies for hemolytic and inflammatory disorders.

Alternate Names for HPX

HPX; hemopexin; HX; beta-1B-glycoprotein;

• 1.Paoli, M., Anderson, B. F., Baker, H. M., Morgan, W. T., Smith, A., & Baker, E. N. Crystal structure of hemopexin reveals a novel high-affinity heme site formed between two β-propeller domains. Nature Structural Biology,, 1999, 6(10), 926-931.